According to PANews, 180 Life Sciences, also known as ETHZilla, has announced its current holdings of 82,186 Ethereum (ETH), acquired at an average price of $3,806.71 per ETH, with a total market value of approximately $349 million. Additionally, the company holds around $238 million in cash equivalents. ETHZilla plans to retain its newly acquired ETH for the long term and aims to generate returns through staking, utilizing a proprietary Ethereum network strategy in collaboration with Electric Capital. The company is accelerating its transformation into an institutional-grade Ethereum reserve management platform while continuing to advance its gaming and biotechnology-related ventures.

#ETHĀ